Lancet Oncology

Oncology & Cancer

Pediatric cancer drug shows 93 percent response rate

A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.

Genetics

Researchers unveil new gene subgroup in prostate cancer

Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.

Oncology & Cancer

Popular weed killer deemed probable carcinogen by UN

One of the world's most popular weed-killers—and the most widely used kind in the U.S.—has been labeled a probable carcinogen by the International Agency for Research on Cancer.

Oncology & Cancer

Overweight linked to 500,000 cancer cases per year

Overweight and obesity is now causing nearly half a million new cancer cases in adults every year, roughly 3.6 percent of the world's total, a study said Wednesday.

Oncology & Cancer

Cancer researchers discover new type of retinoblastoma in babies

A team of Canadian and international cancer researchers led by Dr. Brenda Gallie at the Princess Margaret Cancer Centre, University Health Network (UHN), has discovered a new type of retinoblastoma, a rapidly developing eye ...

Oncology & Cancer

Breast cancer and periods: Link more important in specific cancers

(Medical Xpress)—The younger a woman starts her periods, and the later she finishes, the more at risk she is from developing breast cancer. Now a new study led by Oxford researchers shows that these factors are particularly ...

page 6 from 39